Santa Cruz Biotechnology features a diverse variety of Homocitrate Synthase monoclonal antibodies for research in understanding homocitrate synthase's role in various biological processes. Homocitrate Synthase Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Homocitrate synthase functions as a key enzyme in homocitrate biosynthesis, playing a crucial role in nitrogen metabolism and the regulation of metabolic pathways. The enzyme maintains proper functioning of the urea cycle and participates in various physiological processes, including amino acid metabolism and energy production. Research focused on homocitrate synthase continues to reveal important insights into metabolic disorders and potential therapeutic targets. Investigating homocitrate synthase activity provides valuable information about cellular metabolism and its regulation. Understanding the molecular mechanisms of homocitrate synthase can lead to breakthroughs in metabolic disease research. Exploring homocitrate synthase function helps identify new therapeutic strategies for metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of metabolic pathways and disease mechanisms.